NCT00150202
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
- Locations
-
- Pfizer Investigational Site Nagoya, Aichi-ken, Japan
- Pfizer Investigational Site Urayasu-shi, Chiba, Japan
- Pfizer Investigational Site Tokyo, Chiyoda-ku, Japan
- Pfizer Investigational Site Fukuoka, Japan